Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMLJU5P)

Drug Name
BDBM50080570 Drug Info
Synonyms CHEMBL3126605; SCHEMBL16055394; BDBM50080570
Cross-matching ID
PubChem CID
76325532
TTD Drug ID
DMLJU5P

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Sphingosine-1-phosphate receptor 3 (S1PR3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9522888, 575 DM6UXZK N. A. N. A. Patented [2]
US9617250, Example 1 Example 204 of D1 DM89LKQ N. A. N. A. Patented [1]
YYDJCLCSBYCSCO-UHFFFAOYSA-N DMA91FM N. A. N. A. Patented [3]
US9216972, 61 DM7AHQE N. A. N. A. Patented [4]
US9670220, 77 DMZG1HO N. A. N. A. Patented [5]
US10179791, Compound 296 DMLZBRM N. A. N. A. Patented [6]
JCXGHZCWAHCYGY-UHFFFAOYSA-N DMER7QX N. A. N. A. Patented [3]
US9216972, 67 DMXR5SZ N. A. N. A. Patented [4]
US10166249, Example 695 DMVMNP1 N. A. N. A. Patented [7]
US9181182, 40 DM3QIF4 N. A. N. A. Patented [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sphingosine-1-phosphate receptor 3 (S1PR3) TTDYP7I S1PR3_HUMAN Inhibitor [1]

References

1 Pyridin-4-yl derivatives. US9617250.
2 Substituted bicyclic compounds. US9522888.
3 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis. US9150519.
4 Tricyclic heterocyclic compounds. US9216972.
5 Fused heterocyclic derivatives as S1P modulators. US9670220.
6 Spiro-cyclic amine derivatives as S1P modulators. US10179791.
7 Substituted bicyclic compounds. US10166249.
8 S1P receptors modulators. US9181182.